Polynucleotides and polypeptides involved in gestational malaria, and biological applications
US8563008B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 17, 2008 |
| Grant date | Oct 22, 2013 |
| Priority date | — |
| Expiry date | Nov 4, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The disclosure provides novel antigens involved in gestational malaria, and more particularly to polynucleotide and polypeptide sequences, conjugates, cloning vectors including the sequences for the preparation of immunogenic compositions and vaccines, antibodies, and to their for treating gestational malaria. Diagnostic methods and kits are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.